Article: NewCo News: Nuon Hits The Ground Running With Funding License Deal.

Article from:
BIOWORLD Today
Article date:
November 3, 2009
Copyright

Staff Writer

After completing a $5 million Series A financing last week, Nuon Therapeutics Inc. wasted no time in licensing worldwide rights to autoimmune and inflammatory uses of tranilast from Kissei Pharmaceutical Co. Ltd.

Rodney Pearlman, CEO of San Francisco-based Nuon, said he expects to initiate Phase II clinical trials with tranilast next year in rheumatoid arthritis and multiple sclerosis. Matsumoto City, Japan-based Kissei markets the drug in Japan and Korea for bronchial asthma, keloid and hypertrophic scarring, and allergic conjunctivitis.

Under the terms of the agreement, Nuon licensed autoimmune and inflammatory rights to ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Schaeffer's Daily Market Blog Features Intel, Biogen ...
Business Wire;  June 3, 2005 ;     700+ words ... ... NASDAQ:INTC), Biogen Idec (NASDAQ:BIIB ... Internet Initiative Japan (NASDAQ:IIJI ... period. 10:22 AM Biogen Idec Downgraded by Morgan ... Biotech heavyweight Biogen Idec (NASDAQ:BIIB ... Internet Initiative Japan Rockets Higher According ...

Article: Biogen Idec's Avonex launched in ...
Pharma Marketletter;  November 20, 2006 ;     557 words ...USA-based drug developer Biogen Idec says that its multiple sclerosis therapy Avonex (Interferon beta 1a) is now available in Japan. The Japanese Ministry of Health, Labor and Welfare originally approved the drug, which is the most prescribed ...

Article: Biogen Idec Establishes New International ...
PR Newswire;  July 7, 2004 ;     700+ words ... ... approximately 50 employees and support Biogen Idec's international operations ... In total, close to 500 Biogen Idec employees are based in Europe, Australia, Canada, Japan, and New Zealand. Biogen Idec has had a sales and marketing ...

Article: BIOGEN & IDEC PHARMACEUTICALS COMPLETE MERGER.
AsiaPulse News;  November 13, 2003 ;     700+ words ... ... integration planning process." Biogen Idec begins operations with ... initiatives focused on making Biogen Idec a strategic partner for ... countries, as well as Japan, Canada, Australia and ... of distributors sells Biogen Idec products in over 50 countries ...

Article: BIOGEN IDEC, SEEKING CLOUT IN CANCER DRUGS, TO BUY ...
The Boston Globe;  May 4, 2006 ;     700+ words ... ... Executives in the field said Biogen Idec's acquisition of Conforma ... the board chose the Biogen Idec deal because the companies ... ultimately treat patients. But Biogen Idec did not get all of Conforma ... compound that is sold in Japan to treat lung cancer and ...

Article: Icahn's chances for winning Biogen Idec campaign ...
AP Worldstream;  June 18, 2008 ;     700+ words ... ... an eventual buyout of Biogen Idec by a large pharmaceutical ... Massachusetts-based Biogen Idec, which boasts a healthy ... 8.8 billion bid by Japan's Takeda Pharmaceuticals ... companies being interested in Biogen Idec. On Thursday, Biogen ...

Article: Biogen Idec Getting Conforma In Buyout Worth Up To ...
BIOWORLD Today;  May 4, 2006 ;     700+ words ... ... Cambridge, Mass.-based Biogen Idec is acquiring all of Conforma ... July 2005 from Osaka, Japan-based Dainippon Sumitomo ... the drug as Calsed in Japan since gaining approval ... falls into the hands of Biogen Idec, while the Amrubicin ...

Article: BioWa Announces the Licensing of its Potelligent(TM) Technology ...
PR Newswire;  June 30, 2004 ;     700+ words ... ... products developed by Biogen Idec. Detailed licensing terms ... into a relationship with Biogen Idec, one of the world's foremost biotech companies. Biogen Idec's proven expertise in ... Hakko Kogyo Co., Ltd., Japan's leading pharmaceutical ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives